[144] Entrada Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Form 4 filing overview: Director Dawn E. Hudson reported the receipt of 1,799 shares of NVIDIA common stock on 06/26/2025. The shares are in the form of restricted stock units (RSUs) that were granted at no cash cost as part of the company’s annual equity award for board service. According to the accompanying footnote, the RSUs will vest 50% on 11/19/2025 and 50% on 05/20/2026; all units vest immediately if the director’s service ends due to death.

Following the grant, Hudson’s directly held position rises to 458,887 shares. There were no disposals or sales reported in this filing, and no derivative securities were listed. The transaction was coded “A” (acquisition) and carries a price of $0, confirming it is purely a compensatory award rather than an open-market purchase.

Given NVIDIA’s market capitalization, the incremental 1,799 shares represent an immaterial addition from a corporate-level perspective but continue to align the director’s incentives with shareholder value. No other directors or insiders were included in this filing, and no amendments to prior reports were noted.

Positive

• Director received 1,799 RSUs, further aligning board incentives with shareholder interests

Negative

• None.

Insights

Corporate Governance Analyst

TL;DR — Standard RSU grant; improves alignment, minimal market impact.

This Form 4 discloses the routine annual equity award to a non-employee director. The 1,799-share grant enlarges Hudson’s stake by less than 0.4%, keeping her exposure largely unchanged but reinforcing governance best practice of equity-based compensation. Vesting terms (two equal tranches over 12 months) encourage at-least-one-year board continuity. No red flags—no accelerated vesting clauses beyond death, no outsized award versus peers, and no concurrent sales. Overall, it signals ongoing board engagement but is not financially material to NVDA.

Securities Analyst

TL;DR — Neutral; negligible share count change, no signalling effect.

The acquisition is purely compensatory and carries no cash outlay, thus provides no read-through on insider sentiment regarding valuation. Post-transaction beneficial ownership remains substantial (458.9k shares), but the incremental dilution is infinitesimal relative to NVIDIA’s ~2.5 billion diluted shares outstanding. Trading liquidity and float are unaffected, and no derivative positions were disclosed. Consequently, the filing is administrative rather than market-moving.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	TD Securities (USA) LLC 1 Vanderbilt Ave New York NY 10017	18578	126566.34	37953417	06/30/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/28/2017	Venture Investment	Entrada Therapeutics, Inc.			18578	09/28/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
5AM Ventures V, L.P. 4 Embarcadero Center, Suite 3110 San Francisco CA 94111	Common	06/27/2025	55735	385128.85

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many NVIDIA (NVDA) shares did Director Dawn E. Hudson acquire?

She acquired 1,799 shares in the form of restricted stock units.

What is the vesting schedule for the newly granted RSUs?

The RSUs vest 50% on 11/19/2025 and 50% on 05/20/2026; they vest immediately upon death.

Did the director sell or dispose of any NVIDIA shares in this filing?

No. The Form 4 shows only an acquisition (Code "A"); no sales or disposals were reported.

What is Dawn E. Hudson’s total beneficial ownership after the transaction?

She now beneficially owns 458,887 shares of NVIDIA common stock.

Is this Form 4 expected to impact NVIDIA’s share price?

The grant is routine and immaterial to the company’s float, so it is unlikely to affect NVDA’s market price.